The very public risks of celebrity endorsements

Share this article:
Pam Garfield, Vice President, Patient Health Perspectives, LLC, Seattle, WA
Pam Garfield, Vice President, Patient Health Perspectives, LLC, Seattle, WA

The negative attention surrounding Paula Deen's surprise Type 2 diabetes confession (three years late) and her introduction as a pharma spokesperson have kept many crisis management teams busy.  But this situation highlights a bigger issue that has been brewing, and it's time for our industry to face it head-on.

The question: Should celebrities be enlisted to promote pharmaceutical brands?

Americans love celebrities. In the last decade, a new type of “journalism” has evolved, focusing exclusively on watching every move celebrities make. At the same time, a new category of celebrity has emerged with the rise of reality TV, and these “celebrities” don't need to have any skills or accomplishments. As millions of viewers tune in to watch housewives, teenage moms, and would-be fashion designers, it seems “infamous” and “famous” are merging.

With so much emphasis on celebrity culture, it's no surprise that anyone who can possibly swing it is angling for an endorsement deal. And, with so many famous faces to go around, celebrities are promoting everything from free public restrooms (Kim Kardashian for Charmin) to artificial butter (Ozzy Osbourne for I Can't Believe It's Not Butter).

But are pharmaceutical products really in the same category as mascara, cars, toilet paper, and margarine?  Are healthcare decisions really on par with choosing between a BMW and a Mercedes? And what happens when a celebrity goes off message, gets a DUI, or is photographed eating a hamburger?

Celebrities can have a place in the marketing mix. They can raise awareness of the need for screenings or particular diseases with a single interview or PSA. And the right celebrity can capture the attention of a target demographic with lightening speed. But a marketer who ties a celebrity to a specific brand does so at great risk.

There is a better way. For delivering information about your brand, nothing can beat the authenticity of a real patient, sharing real success, with real passion —without compensation or a hidden agenda. Healthcare is not entertainment. It's real life. Let's give it a real voice.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?